JP2023522065A5 - - Google Patents
Info
- Publication number
- JP2023522065A5 JP2023522065A5 JP2022563012A JP2022563012A JP2023522065A5 JP 2023522065 A5 JP2023522065 A5 JP 2023522065A5 JP 2022563012 A JP2022563012 A JP 2022563012A JP 2022563012 A JP2022563012 A JP 2022563012A JP 2023522065 A5 JP2023522065 A5 JP 2023522065A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- acid
- composition according
- item
- total weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/085241 | 2020-04-17 | ||
| CN2020085241 | 2020-04-17 | ||
| PCT/CN2021/087690 WO2021209025A1 (en) | 2020-04-17 | 2021-04-16 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522065A JP2023522065A (ja) | 2023-05-26 |
| JP2023522065A5 true JP2023522065A5 (https=) | 2024-04-26 |
Family
ID=78084668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563012A Pending JP2023522065A (ja) | 2020-04-17 | 2021-04-16 | 医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230128252A1 (https=) |
| EP (1) | EP4135699A4 (https=) |
| JP (1) | JP2023522065A (https=) |
| KR (1) | KR20230004644A (https=) |
| CN (1) | CN115135323A (https=) |
| AU (1) | AU2021255559A1 (https=) |
| CA (1) | CA3180160A1 (https=) |
| WO (1) | WO2021209025A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240390366A1 (en) * | 2021-11-30 | 2024-11-28 | Mannkind Corporation | Formulation and method for topical treatment of mycobacterium ulcerans in buruli ulcers |
| CN116115563B (zh) * | 2023-03-30 | 2023-08-29 | 石家庄四药有限公司 | 一种氟比洛芬混悬注射液及其制备方法 |
| WO2025026423A1 (en) * | 2023-08-02 | 2025-02-06 | Shenzhen Pharmacin Co., Ltd. | Compositions, their use and manufacture for treatment of gastrointestinal conditions |
| CN117731649B (zh) * | 2023-12-21 | 2025-01-28 | 博济医药科技股份有限公司 | 一种氨甲环酸药物组合物及其制备工艺 |
| CN119837856A (zh) * | 2024-12-11 | 2025-04-18 | 江南大学 | 一种具有预防和改善特应性皮炎的黄酮组合物及其应用 |
| CN120865107B (zh) * | 2025-09-22 | 2026-01-23 | 中国医学科学院医药生物技术研究所 | 一种苯吩嗪衍生物、其制备方法与用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19814814C2 (de) * | 1998-04-02 | 2002-01-31 | Gerhard Steffan | Wasserlösliche, Iminophenazinderivate enthaltende pharmazeutische Zusammensetzungen, deren Herstellung und Verwendung |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| US10179159B2 (en) * | 1999-10-22 | 2019-01-15 | Scott Wepfer | Topical anesthetic formulation |
| CN102225046A (zh) * | 2005-08-05 | 2011-10-26 | 努沃研究公司 | 透皮释药剂型 |
| CA2775393C (en) * | 2012-05-02 | 2014-04-29 | Samy Saad | Topical non-aqueous pharmaceutical formulations |
| US8852648B2 (en) * | 2012-11-06 | 2014-10-07 | Rochal Industries, Llp | Delivery of biologically-active agents using volatile, hydrophobic solvents |
| CN105492004A (zh) * | 2013-02-08 | 2016-04-13 | 罗达制药有限公司 | 治疗局部微生物感染的方法 |
| US20160220710A1 (en) * | 2015-01-30 | 2016-08-04 | The Regents Of The University Of Michigan | Compositions and methods for delivering pharmaceutical agents |
| CN105693668A (zh) * | 2016-04-23 | 2016-06-22 | 贺玉皓 | 一种氯法齐明的药物组合物及其医药用途 |
-
2021
- 2021-04-16 KR KR1020227039987A patent/KR20230004644A/ko active Pending
- 2021-04-16 CA CA3180160A patent/CA3180160A1/en active Pending
- 2021-04-16 CN CN202180015307.7A patent/CN115135323A/zh active Pending
- 2021-04-16 EP EP21787651.5A patent/EP4135699A4/en not_active Withdrawn
- 2021-04-16 AU AU2021255559A patent/AU2021255559A1/en not_active Abandoned
- 2021-04-16 WO PCT/CN2021/087690 patent/WO2021209025A1/en not_active Ceased
- 2021-04-16 JP JP2022563012A patent/JP2023522065A/ja active Pending
-
2022
- 2022-10-11 US US17/963,285 patent/US20230128252A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522065A5 (https=) | ||
| JP2020090499A (ja) | 胃腸管に沿った医薬の標的化放出のためのｐＨ依存性担体、それによる組成物、ならびにこれらの製造および使用 | |
| GB2128087A (en) | Topically administrable anti-inflammatory pharmaceutical compositions | |
| RU2011141102A (ru) | Обогащенные омега-3 рыбные парентеральные питательные эмульсии типа масло в воде | |
| JP5864735B2 (ja) | 非経口オキアミ油の治療用途 | |
| WO2000049992A2 (en) | USE OF FXR, PPARα AND LXRα ACTIVATORS TO TREAT ACNE/ACNEIFORM CONDITIONS | |
| JP2010509204A5 (https=) | ||
| JP2020105183A (ja) | 低水溶性薬剤の低融解イオン性塩の組成物および調製方法 | |
| JP7370317B2 (ja) | 魚油および／またはオメガ３脂肪酸を含むエマルジョンに関する方法および組成物 | |
| US20230398132A1 (en) | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | |
| JP2018515463A5 (https=) | ||
| JP2022538505A5 (https=) | ||
| CN117126069A (zh) | 具有改善的稳定性的制剂 | |
| WO2011018480A1 (fr) | Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale | |
| KR20220161356A (ko) | 자발적 수용이 개선된 조성물 | |
| RU2017137960A (ru) | Применение тиаоксосоединений для уменьшения содержания аро сз | |
| JP2018510206A5 (https=) | ||
| RU2323713C2 (ru) | Косметическая и/или дерматологическая композиция | |
| WO2020094736A1 (en) | Lipidic solutions of nsaids | |
| JP2514995B2 (ja) | 経皮、経粘膜による物質の吸収を促進する組成物 | |
| US20140017301A1 (en) | Drug-free compositions and methods for diminishing peripheral inflammation and pain | |
| CN104619311A (zh) | 囊泡制剂、试剂盒和用途 | |
| CN104411298A (zh) | 囊泡制剂、用途和方法 | |
| WO2011145660A1 (ja) | プロポフォール含有水中油型エマルション組成物 | |
| JPH04244023A (ja) | ω６系不飽和脂肪酸含有薬剤 |